Catalyst Wire Dossier Catalyst Wire Dossier

Elidel R

pimecrolimus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Elidel R, covering 2017-09-29 to 2017-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis [Phase 3]

See pricing